- Report
- March 2025
- 183 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- November 2024
- 140 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- March 2025
- 196 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- August 2024
- 202 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- April 2024
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Drug Pipelines
- December 2024
- 240 Pages
Global
From €2852EUR$3,000USD£2,396GBP
- Report
- September 2024
- 351 Pages
Global
From €3990EUR$4,197USD£3,352GBP
- Report
- June 2024
- 251 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- April 2024
- 101 Pages
Global
From €4421EUR$4,650USD£3,714GBP
- Report
- October 2024
- 186 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 93 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 184 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2025
- 197 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- January 2025
- 50 Pages
Global
From €2376EUR$2,499USD£1,996GBP
- Report
- November 2024
- 300 Pages
Global
From €3798EUR$3,995USD£3,191GBP
- Report
- November 2024
- 750 Pages
Global
From €3798EUR$3,995USD£3,191GBP
- Report
- November 2024
- 650 Pages
Global
From €3798EUR$3,995USD£3,191GBP

The Exosome market is a subset of the biotechnology industry that focuses on the development of exosome-based therapeutics. Exosomes are small vesicles that are released by cells and contain proteins, lipids, and nucleic acids. They are involved in a variety of biological processes, including cell-to-cell communication, and have been shown to have potential therapeutic applications. Exosome-based therapeutics are being developed to treat a range of diseases, including cancer, neurological disorders, and cardiovascular diseases.
Exosome-based therapeutics are still in the early stages of development, but the potential of these treatments has attracted the attention of many biotechnology companies. Some of the companies in the Exosome market include Exosome Diagnostics, Exosome Sciences, Exosome Technologies, Exosome Therapeutics, and Exosome Sciences. Show Less Read more